ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Recurrence
Cancer
Hematologic Cancer
Lymphoma
Smoldering Multiple Myeloma
Leukemia

Multiple Myeloma trials near Taipei City, TWN:

Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients

The goal of this clinical trial is to learn if the antibody drug HuL001, combined withLenalidomide/Dexamethasone works to treat Multiple Myeloma...

Invitation-only
Multiple Myeloma Refractory
Drug: Lenalidomide and Dexamethasone
Biological: HuL001-15 mg/kg

Phase 1, Phase 2

HuniLife Biotechnology

Taipei, Taiwan

doses) of the study medicine (elranatamab) in participants with multiple myeloma that has come back after responding to treatment o ...

Active, not recruiting
Multiple Myeloma
Drug: Elranatamab

Phase 2

Pfizer
Pfizer

Taipei, Taiwan and 51 other locations

Locations recently updated

This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical ben...

Enrolling
Multiple Myeloma
Drug: Elranatamab

Phase 4

Pfizer
Pfizer

Taipei, Taiwan and 24 other locations

doses of single agent belantamab in participants with refractory multiple myeloma (RRMM) who have received at least 3 prior therapi...

Enrolling
Multiple Myeloma
Drug: Belantamab mafodotin
Drug: Belantamab

Phase 1

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Taipei, Taiwan and 20 other locations

Locations recently updated

monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Pa...

Enrolling
Multiple Myeloma
Drug: Lenalidomide
Drug: Elranatamab

Phase 3

Pfizer
Pfizer

Taipei, Taiwan and 218 other locations

with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple...

Active, not recruiting
Multiple Myeloma
Drug: Bortezomib
Drug: Dexamethasone

Phase 3

Celgene
Celgene

Taipei, Taiwan and 265 other locations

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...

Enrolling
Multiple Myeloma
Drug: Carfilzomib
Drug: Etentamig

Phase 3

AbbVie
AbbVie

Taipei City, Taipei, Taiwan and 163 other locations

This study aims to evaluate alternative dosing regimens of single-agent belantamab mafodotin in participants with relapsed or refractory multiple...

Active, not recruiting
Multiple Myeloma
Drug: Belantamab mafodotin

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Taipei, Taiwan and 87 other locations

The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negat...

Enrolling
Multiple Myeloma
Newly Diagnosed Multiple Myeloma
Drug: Daratumumab
Drug: Dexamethasone

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Taipei, Taiwan and 80 other locations

Locations recently updated

The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bispecific antibody elranatamab can provide more benefit to people with multiple...

Enrolling
Multiple Myeloma
Drug: Elranatamab
Drug: Pomalidomide

Phase 3

Pfizer
Pfizer

Taipei, Taiwan and 240 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems